ONWARD Medical Welcomes New Leaders to its Board of Directors
Leadership Transitions at ONWARD Medical
ONWARD Medical N.V., a pioneering medical technology firm focused on spinal cord stimulation therapies, has exciting leadership updates. This renowned company is at the forefront of innovation, and with these changes, it is setting the stage for significant advancements.
Rob ten Hoedt Joins as Incoming Chairman
As part of its strategic evolution, ONWARD Medical is thrilled to announce the addition of Rob ten Hoedt to its Board of Directors. Ten Hoedt, an esteemed leader previously associated with Medtronic, is recognized for his extensive expertise in technology development and his impactful leadership within the medtech industry.
His previous roles include Executive Vice-President and President of Global Regions at Medtronic, where he was instrumental in spearheading initiatives that benefited patients worldwide. Ten Hoedt also served as Chairman of MedTech Europe, where he contributed to the growth and development of the medical technology sector across Europe.
Scheduled to step into the role of Chairman later this year, Ten Hoedt stated, "I am honored and excited to join this exceptional company. I look forward to collaborating with the Board and Management to harness ONWARD's immense potential in addressing unmet medical needs in spinal cord injury treatment." His expected contributions to ONWARD Medical include leveraging his vast network and innovative mindset.
Rahma Samow's Appointment as Director
Joining Ten Hoedt is Rahma Samow, a prominent figure in commercial and digital health. Currently the President and CEO of ClearChoice Dental Implant Centers, Samow brings a wealth of experience from her time on the Executive Management Board at Straumann Group and a notable tenure at Siemens Healthineers.
Samow's extensive background in global sales, marketing, and promotion of digital health initiatives will enhance ONWARD Medical's strategic direction. Dave Marver, CEO of ONWARD Medical, expressed enthusiasm about her appointment, stating, "Rahma's expertise will help us build strong communities among those we serve and enable us to navigate the challenges of commercializing our therapies globally."
Retirement of Long-Standing Board Members
These strategic appointments come as ONWARD bids farewell to its current Chairman Jan Ohrstrom and Director Fred Colen, who will retire after eight years of committed service. Marver acknowledged their invaluable contributions, stating: "Jan has provided unwavering guidance, and Fred's deep industry experience has been crucial for our growth. They have both played an instrumental role in our evolution from a startup to a publicly traded company ready for commercialization."
This transition marks a pivotal moment for ONWARD Medical as it prepares for the upcoming launch of its innovative ARC-EX System in the United States. This system is currently undergoing FDA review, and with the support and experience of Ten Hoedt and Samow, ONWARD is poised for an exciting new chapter.
Commitment to Innovation in Spinal Cord Injury Treatment
ONWARD Medical is dedicated to partnering with the spinal cord injury community, continuously focused on developing effective therapeutic solutions. Its acclaimed ARC therapy has garnered significant attention, receiving numerous Breakthrough Device Designations from the FDA, indicating its potential to truly impact patients' lives.
The company’s research on ARC Therapy focuses on targeted spinal cord stimulation designed to restore movement and function. The ongoing clinical studies, such as the pivotal Up-LIFT trial, have shown promising results in improving upper limb function for individuals with spinal cord injuries.
With headquarters in Eindhoven and operations expanded to Lausanne and Boston, ONWARD Medical exemplifies a global commitment to innovation, collaborating with leading hospitals and universities to propel its mission forward.
Frequently Asked Questions
What recent changes occurred in ONWARD Medical's leadership?
ONWARD Medical appointed Rob ten Hoedt as the new incoming Chairman and Rahma Samow as a member of the Board of Directors.
Who is Rob ten Hoedt?
Rob ten Hoedt is a former executive at Medtronic and has extensive experience in the medtech industry, bringing valuable insights to ONWARD Medical.
What are the main goals for ONWARD Medical moving forward?
ONWARD aims to launch its ARC-EX System while enhancing its therapeutic offerings in spinal cord injury treatment and increasing its market presence.
What is ARC Therapy?
ARC Therapy is an innovative spinal cord stimulation method aimed at restoring movement and functionality for those affected by spinal cord injuries.
How is ONWARD Medical ensuring patient-centered care?
ONWARD Medical is committed to partnering with the spinal cord injury community and engaging in ongoing research to meet specific needs and improve patient outcomes.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- SpaceX's Competitive Pricing Strategy Challenged by Industry Leaders
- InterDigital Partners with UT Austin to Advance AI in Wireless Tech
- Niu Technologies Prepares to Release Q3 2024 Financials
- Getchell Gold Corp. Enhances Market Presence with New Partner
- New Innovations Unveiled at the 2024 Smart City Expo
- MYCOM OSI Welcomes New Leaders: Andrew Coll and Charles Bligh
- Innovative Partnership to Propel Sustainable Travel Forward
- Global Fashion Summit Debuts in China to Promote Sustainability
- ISS A/S Commences New Phase of Share Buyback Initiative
- Emirates SkyCargo Strengthens Growth Strategy with New Freighters
Recent Articles
- Vallourec and ASMO Form Game-Changing Alliance for Energy
- Sanofi and CD&R Partner to Elevate Opella in Consumer Health
- FORVIA Reports Q3 2024 Sales With Strong Growth Amid Challenges
- Cabka Reports Positive Q3 Sales Growth Amidst Challenges
- Boussard & Gavaudan Holding Limited Update on NAV Metrics
- Boussard & Gavaudan Holding Limited: Updated NAV Details
- Sampo plc Expands Share Buyback Program Amid Market Changes
- Thailand Sees Surge in Investment Applications Amid Tech Boom
- ARC Group: A Leader in Investment Advisory Services Industry
- Global Economic Outlook: IMF and World Bank Face Challenges
- Understanding the Dynamics of ASML and TSMC in Semiconductors
- Bigbank AS Secures Success with Unsecured Bond Offering
- VEON Achieves Compliance with Nasdaq After Recent 20-F Filing
- LHV Pank Expands Through Strategic Acquisition of Loans
- Galderma's Latest Findings Showcase RelabotulinumtoxinA Efficacy
- Trailstone and Eurowind Energy Collaborate to Boost Renewables
- VEON Achieves Nasdaq Compliance After 2023 20-F Filing Success
- AI Technology Expansion: Key Insights and Market Predictions
- Support for Pennsylvania Senate Candidates: Crypto's Influence
- Bitcoin Approaches $70,000 Amid Regulatory Optimism
- Sam Altman Chooses Mark Zuckerberg in Hypothetical Cage Match
- SAP's Earnings Report: Key Insights and Market Reactions
- Emerging Market Stocks' Growth Potential Amid Global Changes
- Gary Black Discusses Pragmatic Valuation for Tesla Growth
- Gold Prices Soar Amidst Market Turmoil and Political Uncertainty
- Malaysia's Q3 Economic Growth Insights and Future Projections
- Innovative Intranasal Vaccines by Blue Lake and CyanVac
- Vietnam's Ambitious Economic Growth Plans for 2024 and Beyond
- Emerging Economies Face New Challenges Amid Default Wave
- IBM Unveils Innovative AI Models for Business Growth
- Nokia and VNPT's Groundbreaking 5G Partnership in Vietnam
- Jakarta-Bandung High-Speed Railway Marks Year of Success
- SERES Debuts Luxurious Electric Vehicles Showroom in Region
- Estonia Showcases Innovation and Partnerships at GITEX 2024
- Aiya America Unveils Delicious Sweetened Matcha Latte Pods
- ELFBAR and LOST MARY Unite to Launch UK Advisory Board
- Marriott Bonvoy Empowering Sustainability in Meetings Worldwide
- Ten Years of Rodent Challenges: Chicago Leads the Pack Again
- Strengthening Cybersecurity: The Evolving Role of CISOs
- Crayola's Creative Journey: Celebrate Imagination Worldwide
- RBA Official Highlights Strong Employment Amid Economic Changes
- Chinese AI Companies Innovate to Overcome US Chip Restrictions
- Shiba Inu's Potential Surge: Can It Reach New Heights Soon?
- Discover Why Nu Holdings Is A Smart Investment Now
- Thailand Records Surge in Investment Applications for 2023
- Birthday Cheers For Kamala Harris From Political Giants
- Sticker Mule's 'Vote for Trump' Sign Event Unites Crowd in Fun
- Spire Global, Inc.: Deadline Approaches for Investors to Act
- Strengthening Judicial Ties: Insights from Singapore-China Dialogue
- Market Trends: Asia Shares Ebb While Bitcoin Surges Higher